Johnson Pharmacare Board of Directors
Get the latest insights into the leadership at Johnson Pharmacare. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Ramanlal Trivedi | Whole Time Director & Chief Financial Officer |
| Manisha Maneklal Patel | Non Executive Independent Director |
| Neha Srivastava | Company Secretary & Compliance Officer |
| Parul Agarwal | Non Executive Independent Director |
| Rajender Parsad | Non Executive Director |
| Babita | Non Executive Independent Director |
| Umesh Kumar | Executive Director |
| Dheeraj Kumar | Executive Director |
| Nand Kishore Ray | Non Executive Independent Director |
Johnson Pharmacare FAQs
The board at Johnson Pharmacare consists of experienced professionals, including Ramanlal Trivedi, Manisha Maneklal Patel, and others, overseeing the company’s strategic and corporate governance.
Directors at Johnson Pharmacare are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Ramanlal Trivedi is the current chairman at Johnson Pharmacare.
Executive directors at Johnson Pharmacare are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Johnson Pharmacare adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Johnson Pharmacare, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.
